Ipopema Securities SA
WSE:IPE
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.36
4.06
|
Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ipopema Securities SA
Investor Relations
IPOPEMA Securities SA engages in the provision of brokerage services. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 254 full-time employees. The company went IPO on 2009-05-26. The firm specializes in investment banking services such as preparation and execution of transactions on the capital market using share instruments, debentures and hybrid instruments. Ipopema Securities SA also provides brokerage services as well as company analyses. The Company’s offer is above all addressed to domestic and foreign corporate customers and also includes the access to developed foreign stock markets as well as emerging markets. As of December 31, 2011, the Company operated three subsidiaries, wholly owned Ipopema Towarzystwo Funduszy Inwestycyjnych SA and Ipopema Asset Management, as well as 50.02%-owned Ipopema Business Consulting Sp. z o.o.
IPOPEMA Securities SA engages in the provision of brokerage services. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 254 full-time employees. The company went IPO on 2009-05-26. The firm specializes in investment banking services such as preparation and execution of transactions on the capital market using share instruments, debentures and hybrid instruments. Ipopema Securities SA also provides brokerage services as well as company analyses. The Company’s offer is above all addressed to domestic and foreign corporate customers and also includes the access to developed foreign stock markets as well as emerging markets. As of December 31, 2011, the Company operated three subsidiaries, wholly owned Ipopema Towarzystwo Funduszy Inwestycyjnych SA and Ipopema Asset Management, as well as 50.02%-owned Ipopema Business Consulting Sp. z o.o.